Showing 3,661 - 3,680 results of 18,435 for search 'significant ((((we decrease) OR (((greatest decrease) OR (a decrease))))) OR (mean decrease))', query time: 0.88s Refine Results
  1. 3661

    Feasibility diagram of design points. by Xueyong Pan (20390363)

    Published 2024
    “…The <i>T</i><sub>max</sub> of the battery module decreased by 6.84% from 40.94°C to 38.14°C and temperature mean square deviation decreased (<i>TSD</i>) by 62.13% from 1.69 to 0.64. …”
  2. 3662

    Related parameters of square LIBs. by Xueyong Pan (20390363)

    Published 2024
    “…The <i>T</i><sub>max</sub> of the battery module decreased by 6.84% from 40.94°C to 38.14°C and temperature mean square deviation decreased (<i>TSD</i>) by 62.13% from 1.69 to 0.64. …”
  3. 3663

    Multi objective optimization design process. by Xueyong Pan (20390363)

    Published 2024
    “…The <i>T</i><sub>max</sub> of the battery module decreased by 6.84% from 40.94°C to 38.14°C and temperature mean square deviation decreased (<i>TSD</i>) by 62.13% from 1.69 to 0.64. …”
  4. 3664

    Battery pack model. by Xueyong Pan (20390363)

    Published 2024
    “…The <i>T</i><sub>max</sub> of the battery module decreased by 6.84% from 40.94°C to 38.14°C and temperature mean square deviation decreased (<i>TSD</i>) by 62.13% from 1.69 to 0.64. …”
  5. 3665

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    “…By developing a delivery vector that specifically targets circulating malignant cells (CMCs) in patient blood samples, we established an ex vivo platform to study the dynamic interplay between patient-derived cancer cells and immune cells. …”
  6. 3666

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    “…By developing a delivery vector that specifically targets circulating malignant cells (CMCs) in patient blood samples, we established an ex vivo platform to study the dynamic interplay between patient-derived cancer cells and immune cells. …”
  7. 3667

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    “…By developing a delivery vector that specifically targets circulating malignant cells (CMCs) in patient blood samples, we established an ex vivo platform to study the dynamic interplay between patient-derived cancer cells and immune cells. …”
  8. 3668

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    “…By developing a delivery vector that specifically targets circulating malignant cells (CMCs) in patient blood samples, we established an ex vivo platform to study the dynamic interplay between patient-derived cancer cells and immune cells. …”
  9. 3669
  10. 3670

    Summary of KEGG enrichment analysis. by Zeynab Hosseinpoor (19762319)

    Published 2024
    “…While the expression levels of <i>IRS2</i>, <i>FOXO1</i>, and <i>ERK2</i> (<i>MAPK1</i>) were significantly decreased, the <i>SERPINF1</i> gene exhibited high expression simultaneously. pAAV-delivered <i>MIR-96</i> had no adverse effect on the viability of human RPE cells. …”
  11. 3671
  12. 3672
  13. 3673
  14. 3674

    PCA of bacterial communities. by Jun Sun (48981)

    Published 2025
    “…A significant positive correlation was observed between AK and both <i>Firmicutes</i> and <i>Kapabacteria</i> individually; furthermore, AP exhibited a highly significant positive correlation with <i>Kapabacteria</i> but a significant negative correlation with <i>unidentified Archaea</i>. …”
  15. 3675

    OUT Venn diagram. by Jun Sun (48981)

    Published 2025
    “…A significant positive correlation was observed between AK and both <i>Firmicutes</i> and <i>Kapabacteria</i> individually; furthermore, AP exhibited a highly significant positive correlation with <i>Kapabacteria</i> but a significant negative correlation with <i>unidentified Archaea</i>. …”
  16. 3676

    Histogram of the area factorψ. by Hong Zhang (25820)

    Published 2025
    “…The measured <i>I</i><sub>s</sub> decreases following a power-law trend as <i>β</i> and <i>D</i> increase, with weathering reducing the sensitivity of <i>I</i><sub>s</sub> to <i>β</i> but not significantly altering its sensitivity to <i>D</i>. …”
  17. 3677

    Raw dataset Fig. 6. by Hong Zhang (25820)

    Published 2025
    “…The measured <i>I</i><sub>s</sub> decreases following a power-law trend as <i>β</i> and <i>D</i> increase, with weathering reducing the sensitivity of <i>I</i><sub>s</sub> to <i>β</i> but not significantly altering its sensitivity to <i>D</i>. …”
  18. 3678
  19. 3679

    Schematic for measuring <i>D</i> and <i>D</i>′ values. by Hong Zhang (25820)

    Published 2025
    “…The measured <i>I</i><sub>s</sub> decreases following a power-law trend as <i>β</i> and <i>D</i> increase, with weathering reducing the sensitivity of <i>I</i><sub>s</sub> to <i>β</i> but not significantly altering its sensitivity to <i>D</i>. …”
  20. 3680

    Primer sequences for RT-qPCR. by Wenlong Shen (9313937)

    Published 2025
    “…Data from TCGA showed that NCOA4 shows greater downgrade in tumor tissues than in non-tumor tissues and the overall survival (OS) of patients with low NCOA4 expression was significantly shorter than that of patients with high NCOA4 expression.The qPCR results showed that NCOA4 was expressed at low levels in cholangiocarcinoma tissue specimens; the mRNA expression of NCOA4 decreased after knocking down NCOA4 in cells. …”